RespireRX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, ADHD, spinal cord injury and other neurological conditions. RespireRX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, ADHD, spinal cord injury and other neurological conditions.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0016 | -66.6666666667 | 0.0024 | 0.0024 | 0.0008 | 158263 | 0.00199806 | CS |
4 | 0 | 0 | 0.0008 | 0.0024 | 0.0007 | 295443 | 0.00136006 | CS |
12 | 0.0001 | 14.2857142857 | 0.0007 | 0.0025 | 0.0006 | 646571 | 0.0012665 | CS |
26 | -0.0001 | -11.1111111111 | 0.0009 | 0.0025 | 0.0003 | 710607 | 0.0011923 | CS |
52 | -0.0008 | -50 | 0.0016 | 0.0069 | 0.0002 | 12238734 | 0.00264835 | CS |
156 | -0.0132 | -94.2857142857 | 0.014 | 0.0191 | 0.0002 | 6458566 | 0.00225864 | CS |
260 | -0.0942 | -99.1578947368 | 0.095 | 0.1499 | 0.0002 | 6253229 | 0.00487583 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales